Tommy Tuberville's HUMA trades
- The latest HUMA trade was a sale on May 3, 2024, when HUMA closed at $4.41. It closed at $0.46 on Nov 9, 2026 (-90%).
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
Tommy Tuberville reported 5 HUMA transactions in 2 filings with the Senate eFD for 2025–2026: 3 purchases and 2 sales of Humacyte, Inc. - Common Stock, with trade dates from Mar 21, 2024 to May 3, 2024. The median gap between trade date and filing date is 867 days, and 5 trades were reported more than 45 days after it happened.
- 5
- 3 / 2
- $33K to $145K
- 2026-08-05
HUMA transactions reported by Tommy Tuberville
| Type | Owner | ||||
|---|---|---|---|---|---|
Humacyte, Inc. - Common Stock HUMA | Sale | Joint | $1,001 - $15,000 | 2026-08-05 #0a25588d-a3f8-4ed6-971a-706097f78e3a | |
Humacyte, Inc. - Common Stock HUMA | Sale | Joint | $15,001 - $50,000 | 2026-08-05 #0a25588d-a3f8-4ed6-971a-706097f78e3a | |
Humacyte Inc HUMA | Purchase | Joint | $1,001 - $15,000 | 2026-08-05 #548cacbf-7cf2-42cb-9f23-71250938caae | |
Humacyte, Inc. - Common Stock HUMA | Purchase | Joint | $1,001 - $15,000 | 2026-08-05 #548cacbf-7cf2-42cb-9f23-71250938caae | |
Humacyte, Inc. - Common Stock HUMA | Purchase | Joint | $15,001 - $50,000 | 2026-08-05 #548cacbf-7cf2-42cb-9f23-71250938caae |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 5 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 0
- 31–45 days
- 0
- Over 45 days
- 5
- Median / longest
- 867d / 867d
Source documents
2 Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #0a25588d-a3f8-4ed6-971a-706097f78e3aFiled 2026-08-05 · 2 rows
- #548cacbf-7cf2-42cb-9f23-71250938caaeFiled 2026-08-05 · 3 rows
What Tommy Tuberville's HUMA filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Issue 07: The Vote That Knocked Almost a Quarter off Data Center Stocks
Texas has frozen new data center approvals since the summer. The vote extends that freeze, but it cannot unplug campuses that already have power. We map who is exposed, test whether the sell-off overshot and say where the real risk sits.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchMore tickers reported by Tommy Tuberville
Tommy Tuberville and HUMA: questions
Did Tommy Tuberville buy or sell HUMA?
Senate eFD filings for 2025 and 2026 show 3 purchases and 2 sales of Humacyte, Inc. - Common Stock (HUMA) reported by Tommy Tuberville, between 2024-03-21 and 2024-05-03. Reported owner: Joint.
How much HUMA did Tommy Tuberville trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $33K to $145K across 5 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last HUMA filing by Tommy Tuberville?
The most recent filing that includes a HUMA trade was filed on 2026-08-05. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Humacyte, Inc. - Common Stock. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Tommy Tuberville HUMA disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included